CELH
Celsius Holdings, Inc.
CELH has the edge over NATR overall, supported by stronger fundamentals and stronger modeled upside.
NATR
Nature's Sunshine Products, Inc.
NATR trails on the overall score without a compensating advantage in the available component scores.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
NATR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Under pressure | |
| Strong |
NATR's profitability and balance sheet are currently healthy, and its revenue is stable, but its cash flow is under pressure.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
NATR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $10.28 | — |
| Current | 13x | $10.28 | — |
| Cheap | 15x | $12.15 | +18% |
| Fair | 19x | $15.43 | +50% |
| Expensive | 33x | $27.23 | +165% |
Historical ranges are pointers, not guarantees.
NATR has the edge over CELH in the historical PE scenario, which offers more potential upside but is not a forecast.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over NATR on the outlook, with more favorable valuation and earnings expectations.
NATR Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Decline | |
| Decline | |
| Stable | |
| Limited | |
| Low |
Analysts expect NATR's earnings and revenue to decline, though with profitability holding steady. However, they disagree widely on these estimates.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
NATR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.83 | +1.2% |
| Q3 2026 | $0.82 | +1.2% |
| Q2 2026 | $1.01 | +36% |
| Q1 2026 | $1.10 | +108% |
| Q4 2025 | $1.06 | +165% |
| Q3 2025 | $0.81 | -8% |
| Q2 2025 | $0.74 | -7.5% |
| Q1 2025 | $0.53 | -38% |
| Q4 2024 | $0.40 | -48% |
NATR has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH's revenue has grown year over year for six quarters in a row: $847M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over NATR on profitability, with a higher operating margin.
NATR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $116.6M | -9.1% |
| Q2 2026 | $117M | +1.9% |
| Q1 2026 | $122.9M | +8.5% |
| Q4 2025 | $123.8M | +4.7% |
| Q3 2025 | $128.3M | +12% |
| Q2 2025 | $114.8M | +3.8% |
| Q1 2025 | $113.2M | +2% |
| Q4 2024 | $118.2M | +8.5% |
NATR's revenue grew through 2024 and has held roughly level since: $117M last quarter, down 9.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.5% | -2.5 points |
| Q2 2026 | 4.7% | +1 points |
| Q1 2026 | 7.8% | +2.3 points |
| Q4 2025 | 4.3% | +0.4 points |
| Q3 2025 | 7% | +2.4 points |
| Q2 2025 | 3.7% | -1.4 points |
| Q1 2025 | 5.5% | +1.3 points |
| Q4 2024 | 3.9% | -1.4 points |
NATR's operating margin was 4.5% last quarter, down 2.5 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
NATR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $9.2M | -45% |
| Q2 2026 | -$1.9M | -165% |
| Q1 2026 | -$4.3M | -389% |
| Q4 2025 | $7.6M | -24% |
| Q3 2025 | $16.8M | +113% |
| Q2 2025 | $3M | +$5M |
| Q1 2025 | $1.5M | +$3M |
| Q4 2024 | $10M | +20% |
NATR still generates free cash flow, though less than at its 2025 peak: $11M over the past year.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over NATR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
NATR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.5% | -467K shares |
| 1 year | -0.9% | -164K shares |
| 3 years | -8.3% | -1.6M shares |
| 5 years | -12% | -2.5M shares |
| Available history | -9.1% | -1.8M shares |
NATR has 18M diluted shares, down 0.9% from a year ago, with $8M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.5M |
| Q2 2026 | $2.1M |
| Q1 2026 | $500,000 |
| Q4 2025 | $1.9M |
| Q3 2025 | $2M |
| Q2 2025 | $11.9M |
| Q1 2025 | $476,000 |
| Q4 2024 | $423,000 |
NATR spent $8M buying back its own shares over the past year, down 46% from the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
NATR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.3x | Net Cash |
| Q2 2026 | -1.9x | Net Cash |
| Q1 2026 | -2.1x | Net Cash |
| Q4 2025 | -2.4x | Net Cash |
| Q3 2025 | -2.5x | Net Cash |
| Q2 2025 | -2.3x | Net Cash |
| Q1 2025 | -2.4x | Net Cash |
| Q4 2024 | -2.5x | Net Cash |
NATR has the edge over CELH on leverage, with a lower net debt burden relative to earnings.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
NATR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 17.8 | Oversold |
| Stochastic | 9.2 | Oversold |
NATR's weekly RSI is 18 (oversold) and its Stochastic is 9 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
NATR PE vs Consumer Defensive Sector
| Metric | NATR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 19x | 36% below |
| PE % | 10 | 18 | 8 pts below |
NATR has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over NATR on trend strength, trading above more of its moving averages.
NATR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.0 | 15% below |
| 20 week MA | $15.0 | 32% below |
| 50 week MA | $20.3 | 49% below |
| 100 week MA | $17.6 | 42% below |
| 200 week MA | $16.2 | 37% below |
NATR is in a downtrend: it's below all five of its weekly moving averages, and 37% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over NATR on returns for 2026, with the stronger performance.
NATR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.86 | $14.6 | +65% |
| 2021 | $14.6 | $18.3 | +26% |
| 2022 | $18.3 | $8.52 | -54% |
| 2023 | $8.52 | $17.3 | +103% |
| 2024 | $17.3 | $15.0 | -13% |
| 2025 | $15.0 | $21.6 | +44% |
| 2026 YTD | $21.6 | $10.3 | -52% |
NATR's yearly returns have swung widely, from +103% in 2023 to −54% in 2022. It's down 52% so far in 2026.